Background And Aims: Coronavirus disease 2019 (COVID-19) vaccines were rapidly implemented globally and vaccine-associated immune-related hepatitis was recently reported. We aim to investigate its impact in regions endemic of chronic hepatitis B (CHB).
Methods: We retrospectively collected patients who developed hepatitis within 90 days after COVID-19 vaccination in Taiwan.